Analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report released on Monday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Trading Up 34.7 %
Shares of CO opened at $2.99 on Monday. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The stock has a market cap of $363.44 million, a P/E ratio of 4.67 and a beta of 0.16. The stock’s 50-day moving average price is $1.35 and its two-hundred day moving average price is $1.38.
Global Cord Blood Company Profile
Further Reading
- Five stocks we like better than Global Cord Blood
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.